Table 3 Economic analysis of the three screening groups
Group | Cost (RMB) | Cost-effectiveness | Cost-benefit | Cost-utility | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Positive detection rate (%) | Positive predictive value (%) | Referral rate of colposcopy (%) | CER (RMB) | Benefit (RMB) | NPV (RMB) | BCR | DALYs | CUR (RMB) | ||
VIA/VILI | 118550.6 | 1.39 | 10.53 | 13.19 | 8467.9 | 376562.1 | 258011.5 | 3.18 | 50.624 | 2341.8 |
TCT | 99212.6 | 0.30 | 6.98 | 4.25 | 33070.9 | 60628.7 | −38583.9 | 0.61 | 17.603 | 5636.1 |
HPV test | 99566.8 | 0.70 | 4.80 | 5.29 | 14223.8 | 246778.1 | 147211.3 | 2.48 | 42.301 | 2353.8 |